Acquiring Company
Villya Pharmaceuticals
Acquired Company
Hythlayn
Description
Villya Pharmaceuticals has entered the hemp-derived THC beverage market by acquiring the cannabinoid intellectual property of Hythlayn Inc. This acquisition enhances Villya's capabilities in developing innovative solutions for water-based beverages. Villya aims to license the technology to a major global beverage partner, without intending to manufacture beverages itself. This strategic move coincides with an upcoming regulatory shift in the U.S. hemp-derived cannabinoid industry.
Don't miss Villya Pharmaceuticals's next move
Get an email the moment Villya Pharmaceuticals makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Hythlayn?
Hythlayn was acquired by Villya Pharmaceuticals, based in Melbourne. The deal was reported on August 12, 2026. Villya Pharmaceuticals, located in Melbourne, FL, focuses on developing innovative drug delivery systems and new therapeutic solutions aimed at improving patient outcomes across various medical fields. Villya Pharmaceuticals is privately held and operates in Biotechnology.
When did Villya Pharmaceuticals acquire Hythlayn?
Villya Pharmaceuticals's acquisition of Hythlayn was reported on August 12, 2026. Villya Pharmaceuticals has entered the hemp-derived THC beverage market by acquiring the cannabinoid intellectual property of Hythlayn Inc. This acquisition enhances Villya's capabilities in developing innovative solutions for water-based beverages. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Hythlayn do?
Hythlayn Inc. specializes in cannabinoid intellectual property and technology. The company has developed innovative methods for improving cannabinoid solubility. Hythlayn holds several patents aimed at enhancing the beverage industry. It is privately held, operating in Manufacturing.